Target intelligence / Profile preview

RNA, variant U1 small nuclear 2A (RNVU1-2A)

Target
RNVU1-2A
Molecular classification
Other, Noncoding RNA, Small nuclear RNA (snRNA), snRNA variant, Pseudogene
01

Overview

RNA, variant U1 small nuclear 2A (RNVU1-2A) is a transcript belonging to the family of variant U1 snRNAs, which are noncoding RNAs transcribed by RNA polymerase II. The canonical U1 snRNA is a key component of the spliceosome, facilitating the removal of introns from pre-mRNA. Variant U1 snRNAs, including RNVU1-2A, differ from canonical U1 at several nucleotide positions and may be expressed in a tissue- or cell-type-specific manner. They are thought to contribute to the fine-tuning of alternative splicing and to the regulation of transcript isoforms, particularly during stem cell differentiation and cell fate decisions. Most vU1 snRNAs, including RNVU1-2A, show lower expression and limited ability to substitute for U1 in splicing assays; their biological roles remain incompletely characterized, but imbalance between canonical U1 and variants has been associated with motor neuron disease and possibly other neurodevelopmental disorders.

Other names
vU1.2aRNVU1.2aRNU1-12PRNU1P2U1P2ARNA, U1 small nuclear 12 (pseudogene)RNA, U1 small nuclear pseudogene 2RNA, variant U1 small nuclear 11RNVU1-2A
02

Biological functions

Pre-mRNA splicingRNA processingRegulation of alternative splicingRegulation of cell fate (notably in stem cells)
03

Disease associations

Other (Not a well-characterized direct disease gene; imbalance between U1 and its variants implicated in neurodegenerative disease and motor neuron disease such as Spinal Muscular Atrophy)

Beyond the preview

Go deeper on RNA, variant U1 small nuclear 2A (RNVU1-2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, variant U1 small nuclear 2A (RNVU1-2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call